Niro Ramachandran - Mar 23, 2024 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Chief Business Officer
Signature
/s/ Niro Ramachandran, Ph.D., by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Mar 23, 2024
Transactions value $
-$9,609
Form type
4
Date filed
3/25/2024, 05:14 PM
Previous filing
Mar 1, 2024
Next filing
Nov 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Tax liability -$9.61K -2.01K -0.96% $4.79 208K Mar 23, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to cover taxes on a restricted stock unit award previously granted March 23, 2022, which vests in four (4) annual equal installments beginning on March 23, 2023 and annually thereafter until fully vested.